PHARMAC seeks clinical feedback on its cost-utility analysis methodology.
Grocott
Rachel
R
Moodie
Peter
P
D003362:Cost-Benefit Analysis / Q000379:methods; D004335:Drug and Narcotic Control; D017850:Economics, Pharmaceutical; D006801:Humans; D009520:New Zealand